Ruolan Wang - Concepedia

Author

Ruolan Wang

Wuhan National Laboratory for Optoelectronics ORCID

Also Known As

RuoLan Wang, Ruolan Wang, Wang, Ruolan, Yifan Zhang

Publications

1.9K

Citations

H-Index

Concepts

All Affiliations

Wuhan National Laboratory for Optoelectronics Huazhong University of Science and Technology University of Nottingham Beihang University GlaxoSmithKline (United Kingdom)

About

Ruolan Wang is an author at Wuhan National Laboratory for Optoelectronics specializing in engineering, photonics, and applied physics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Engineering	9	9	232
2	Medicine	4	4	395
3	Arts	3	3	139
4	Education	3	3	74
5	Natural Sciences	1	1	221

Ruolan Wang

Publications

1.5K

Citations

H-Index

Page 1

	Year	Citations
Efficacy and Safety of Switching to Dolutegravir/Lamivudine Fixed-Dose 2-Drug Regimen vs Continuing a Tenofovir Alafenamide–Based 3- or 4-Drug Regimen for Maintenance of Virologic Suppression in Adults Living With Human Immunodeficiency Virus Type 1: Phase 3, Randomized, Noninferiority TANGO Study Jean van Wyk, Faïza Ajana, Fiona Bisshop, Clinical Infectious Diseases	2020	257
Dolutegravir (S/GSK1349572) Exhibits Significantly Slower Dissociation than Raltegravir and Elvitegravir from Wild-Type and Integrase Inhibitor-Resistant HIV-1 Integrase-DNA Complexes Kendra E. Hightower, Ruolan Wang, Felix Deanda, Antimicrobial Agents and Chemotherapy ImmunologyMolecular BiologySlower DissociationAntiviral DrugDrug Resistance	2011	221
Identification of 1,5-Naphthyridine Derivatives as a Novel Series of Potent and Selective TGF-β Type I Receptor Inhibitors Françoise Gellibert, James M. Woolven, Marie-Hélène Fouchet, Journal of Medicinal Chemistry	2004	217
Efficacy and Safety of Switching to Dolutegravir/Lamivudine Versus Continuing a Tenofovir Alafenamide–Based 3- or 4-Drug Regimen for Maintenance of Virologic Suppression in Adults Living With Human Immunodeficiency Virus Type 1: Results Through Week 144 From the Phase 3, Noninferiority TANGO Randomized Trial Olayemi Osiyemi, Stéphane De Wit, Faïza Ajana, Clinical Infectious Diseases	2022	123
Developing digital fluency through ubiquitous mobile devices: Findings from a small-scale study Ruolan Wang, Rolf Wiesemes, Cathy Gibbons Computers & Education Digital LiteracyEngineeringSmall-scale StudyUbiquitous LearningMobile Learning	2011	99
N-(3-Cyano-4,5,6,7-tetrahydro-1-benzothien-2-yl)amides as potent, selective, inhibitors of JNK2 and JNK3 Richard Angell, Francis Atkinson, Murray J. B. Brown, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryMedicineRational Drug DesignDrug DevelopmentPharmacology	2006	90
Different forms of selenium supplementation in fish feed: The bioavailability, nutritional functions, and potential toxicity Lei Wang, Gladstone Sagada, Ruolan Wang, Aquaculture NutritionNutrient BioavailabilityDietary ExposureSelenium DeficiencyAnimal Nutrition	2021	54
Brief Report: Durable Suppression and Low Rate of Virologic Failure 3 Years After Switch to Dolutegravir + Rilpivirine 2-Drug Regimen: 148-Week Results From the SWORD-1 and SWORD-2 Randomized Clinical Trials Jean van Wyk, Chloe Orkin, Rafael Rubio, JAIDS Journal of Acquired Immune Deficiency Syndromes	2020	47
Medical students’ perceptions of video-linked lectures and video-streaming Ruolan Wang, Karen Mattick, Elisabeth Dunne ALT-J	2010	37
Soliton Burst and Bi‐Directional Switching in the Platform with Positive Thermal‐Refractive Coefficient Using an Auxiliary Laser Yanjing Zhao, Liao Chen, Chi Zhang, Laser & Photonics Review	2021	37

Page 1